This data is related to our paper “Small molecules preventing GAPDH aggregation are therapeutically applicable in cell and rat models of oxidative stress” (Lazarev et al. [1]) where we explore therapeutic properties of small molecules preventing GAPDH aggregation in cell and rat models of oxidative stress. The present article demonstrates a few of additional properties of the chemicals shown to block GAPDH aggregation such as calculated site for targeting the enzyme, effects on GAPDH glycolytic activity, influence on GAPDH intracellular level and anti-aggregate activity of pure polyglutamine exemplifying a denatured protein
AbstractGlyceraldehyde-3-phosphate dehydrogenase (GAPDH), a homotetrameric enzyme involved in a key ...
AbstractGlyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a classic glycolytic enzyme, and accumul...
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) has recently gained attention as an antiprotozoan a...
AbstractThis data is related to our paper “Small molecules preventing GAPDH aggregation are therapeu...
AbstractProteins with long polyglutamine repeats form a complex with glyceraldehyde-3-phosphate dehy...
Polyglutamine expansion in certain proteins causes neurodegeneration in inherited disorders such as ...
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is one of the key redox-sensitive proteins whose ac...
Polyglutamine expansion in certain proteins causes neurodegeneration in inherited disorders such as ...
Early drug discovery is plagued by nonspecific molecules, which cannot be developed into drugs. Thes...
These data are related to our paper “GAPDH-targeted therapy – a new approach for secondary damage af...
Glycolytic enzymes are attractive anticancer targets. They also carry out numerous, nonglycolytic "m...
SummaryGlycolytic enzymes are attractive anticancer targets. They also carry out numerous, nonglycol...
Glyceraldehyde-3-phosphate dehydrogenase's (GAPDH's) competitor of Siah Protein Enhances Life (GOSPE...
The main aim of my project was to investigate pathways involved in protecting against the toxicity c...
Polyglutamine (polyQ) disorders, including Huntington's disease (HD), are caused by expansion of pol...
AbstractGlyceraldehyde-3-phosphate dehydrogenase (GAPDH), a homotetrameric enzyme involved in a key ...
AbstractGlyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a classic glycolytic enzyme, and accumul...
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) has recently gained attention as an antiprotozoan a...
AbstractThis data is related to our paper “Small molecules preventing GAPDH aggregation are therapeu...
AbstractProteins with long polyglutamine repeats form a complex with glyceraldehyde-3-phosphate dehy...
Polyglutamine expansion in certain proteins causes neurodegeneration in inherited disorders such as ...
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is one of the key redox-sensitive proteins whose ac...
Polyglutamine expansion in certain proteins causes neurodegeneration in inherited disorders such as ...
Early drug discovery is plagued by nonspecific molecules, which cannot be developed into drugs. Thes...
These data are related to our paper “GAPDH-targeted therapy – a new approach for secondary damage af...
Glycolytic enzymes are attractive anticancer targets. They also carry out numerous, nonglycolytic "m...
SummaryGlycolytic enzymes are attractive anticancer targets. They also carry out numerous, nonglycol...
Glyceraldehyde-3-phosphate dehydrogenase's (GAPDH's) competitor of Siah Protein Enhances Life (GOSPE...
The main aim of my project was to investigate pathways involved in protecting against the toxicity c...
Polyglutamine (polyQ) disorders, including Huntington's disease (HD), are caused by expansion of pol...
AbstractGlyceraldehyde-3-phosphate dehydrogenase (GAPDH), a homotetrameric enzyme involved in a key ...
AbstractGlyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a classic glycolytic enzyme, and accumul...
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) has recently gained attention as an antiprotozoan a...